Others

The company is strategically managed by a team of young people that stand out for their integrity, expertise and professionalism and who continuously bring the energy, enthusiasm and dynamism necessary to satisfy the requirements of an ever more demanding and developing market. G21 has its own product portfolio (among which long-term implantable devices and Class III medical devices) of which it fully possesses the know-how as well as the design and production technology, the result of Research and Development programs conducted in-house and in collaboration with major international research institutes and Universities.

High-quality raw materials, absolute process control, compliance with the most stringent international standards, continuous personnel training and painstaking care to details: this is the profile of G21's in-house production unit, which includes clean rooms certified up to Class ISO 5 to guarantee a production process under sterile conditions. Manufacture the products complying with the most stringent quality standards and distribute them internationally in collaboration with trade partners with whom establish and maintain long-term relationships based on trust, cooperation and responsibility.

Since 2010 G21 has been operating according to a quality system in compliance with EN ISO 13485 "Quality Management Systems

- Requirements for regulatory purposes applicable to Medical Devices".

G21 BONE CEMENTS FOR ORTHOPAEDICS are intended to be used during surgical interventions caused by:

• Arthroplasty revision
• Joint replacement after a traumatic event
• Osteoarthritis
• Osteoporosis hangover G21 bone cements for orthopaedics with antibiotic a self-curing, radiopaque, polymethyl methacrylate
  based cement which is used for securing a metal or polymeric prosthesis to living bone in arthroplasty revision procedures such as hip replacement, knee replacement, ankle replacement, shoulder replacement and other joints replacement, specifically formulated for patients:
• where the general or local conditions indicate an increased risk of infection
• with a compromised general state (malnutrition, diabetes, systemic infections,…)
• needing a revision of hip or other joints prosthe-sis where a local infection has developed.
  The G21 bone cements for orthopaedics comes in the form of a two-component system (powder and liquid) to be mixed at the time of application in the operating theatre - is formulated so as to develop the right viscosity for the type of application and such that, once hardened, it assumes a compact structure which enhances the mechanical strength of the implant